Pro Numb tattoo numbing spray recalled for manufacturing standard violations
Pro Numb Tattoo Numbing Spray (lot J15) is recalled nationwide due to manufacturing process deviations. The voluntary recall was initiated February 2, 2026.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a FDA Class II recall with no reported illnesses or injuries, initiated voluntarily by the manufacturer for manufacturing process deviations. The hazard is theoretical rather than confirmed.
Plain-English summary
Pro Numb Tattoo Numbing Spray for Sensitive Skin, containing 4% Lidocaine, in 1 FL OZ or 4 OZ bottles (Lot Number J15), is being recalled nationwide. The product is manufactured by Pro Numb Tattoo Numbing Spray LLC, located in Melbourne, Florida.
The manufacturer voluntarily initiated the recall due to deviations from current Good Manufacturing Practice (cGMP) standards in the manufacturing process. The FDA has classified this as a Class II recall.
Consumers who have purchased this product should stop using it. For more information or questions, consumers can contact the manufacturer or their healthcare provider.
The recalled product
- Product
- PRO NUMB SENSITIVE SKIN (NUMBING SPRAY)
- Brand
- PRO NUMB SENSITIVE SKIN
- Manufacturer
- Pro Numb Tattoo Numbing Spray LLC
- Category
- Drug — Topical Anesthetic
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Number J15
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27